Skip to main content
. 2022 Jul 22;12:12562. doi: 10.1038/s41598-022-15157-y

Table 4.

Risk evaluation for AFM1 via consumption of brukina samples obtained from Greater Accra region of Ghana.

Locality Av. body wgt. (kg) Estimated daily intake (EDI) (ng/kg bw/day) Hazard Index (H.I) Cancer risk (cases/100,000 person/yr)
Nima Infants (0–11 mths) 2.9 0.64 3.2 0.0206
Toddlers (12–35 mths) 9.8 0.38 1.90 0.0122
Children (36 mths–10 yrs) 26 0.14 0.70 4.52 × 10–3
Adolescents (11–17 yrs) 46.25 0.079 0.40 2.55 × 10–3
Adults (18–64 yrs) 60.7 0.061 0.31 1.97 × 10–3
Madina Infants (0–11 mths) 2.9 1.185 5.93 0.038
Toddler (12–35 mths) 9.8 0.70 3.50 0.02261
Children (36 mths–11 yrs) 26 0.264 1.30 8.52 × 10–3
Adolescents (11–17 yrs) 46.25 0.149 0.75 4.813 × 10–3
Adults (18–64 yrs) 60.7 0.113 0.57 3.65 × 10–3

Mean of AFM1—Nima = 0.27 µg/kg, Madina = 0.5017 µg/kg.

Daily intake of milk for infants was halved (0.5 × 0.0137 kg).

Average body weights were obtained from the different ranges referenced by the authors.

Average potency for AFM1 = 0.0323.

1 µg = 1000 ng.

H.I Hazard Index.